54 parallel-programming-"Intelligent-Systems-Group" positions at Vanderbilt University
Sort by
Refine Your Search
-
, challenges and opportunities related to innovation in drug development and the forces shaping the industry KEY JOB OBJECTIVE The analyst will work within the Editorial group to create value-add
-
in a collegial environment and join a multidisciplinary, diverse team in a well-stablished, well-funded research group, currently 35+ dynamic members, developing bioinformatics, analyzing multi omics
-
. Helmsley colleagues are intelligent, creative, forward thinking, and strongly committed to working productively with our grantee partners. Each was drawn to Helmsley by the same opportunity: to help
-
not crucial). 3. Ability to clearly communicate research findings through oral presentation and written publication. 4. Ability to work independently and in a collaborative manner with a diverse group
-
crucial). 3. Ability to clearly communicate research findings through oral presentation and written publication. 4. Ability to work independently and in a collaborative manner with a diverse group of
-
cellular biology as well as experience working in insect systems and common molecular biological techniques as a requirement. In addition, experience with DNA/RNAseq, cell-based membrane protein
-
Organization: Cellular Immunology Group, Laboratory of Bacterial Polysaccharides, Center for Biologics Evaluation and Research of the US FDA (CBER/FDA), Silver Spring, MD. Project description: We
-
. (in pharmaceutical sciences, pharmacology, data science, informatics, public health, or epidemiology-related fields) or a PharmD degree. Possesses strong R programming skills in data analysis and a
-
Organization: Cellular Immunology Group, Laboratory of Bacterial Polysaccharides, Center for Biologics Evaluation and Research of the US FDA (CBER/FDA). Background: Our laboratory is investigating
-
Organization: Cellular Immunology Group, Laboratory of Bacterial Polysaccharides, Center for Biologics Evaluation and Research of the US FDA (CBER/FDA) Background: Our laboratory is investigating the